![Tine Kold Olesen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Tine Kold Olesen is currently the Chief Executive Officer at Biosergen AB. Prior to this role, Dr. Olesen obtained an MBA from Imperial College London.
Dr. Olesen also holds a graduate degree from the University of Copenhagen and a doctorate degree from Ghent University.
Postes actifs de Tine Kold Olesen
| Sociétés | Poste | Début |
|---|---|---|
| BIOSERGEN AB | Directeur Général | 01/02/2024 |
Formation de Tine Kold Olesen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
Choisissez Zonebourse 
